Biomimetic Therapeutics, Inc. Receivables Turnover Ratio (BMTI), from the third quarter 2012 to the third quarter 2011 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Biomimetic Therapeutics, Inc.  (BMTI)
 

Biomimetic Therapeutics Accounts Receivables Turnover Ratio from the third quarter 2012 to the third quarter 2011

Quarterly Results, Trends, Rankings, Statistics


Biomimetic Therapeutics, Inc.'s ability to collect accounts receivable sequentially worsen to 12.89, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Biomimetic Therapeutics's Accounts Receivable average collection period in the Sep 30 2012 quarter, has increased to 28 days, from 18 days, in the Jun 30 2012 quarter.

If we take a look into Healthcare sector 59 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2012 from 0 to 919.

What is Receivable Turnover Ratio?
What is Biomimetic Therapeutics, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMTI Receivables Turnover Ratio (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter
Y / Y Receivable Change 466.27 % 111.52 % 1005.9 % - -
Y / Y Revenue Change 60.68 % -0.5 % 16.97 % 29.81 % 14.42 %
Receivable Turnover Ratio (TTM) 12.89 20.46 24.75 32.97 52.46
BMTI's Total Ranking # 919 # 0 # 0 # 0 #
Accounts Receivable average collection period days 28 18 15 11 7
Seq. Receivable Change 203.84 % 29.34 % 3.16 % 39.67 % 13.49 %
Seq. Revenue Change 57.56 % -6.28 % 1.75 % 6.94 % -2.44 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 8
Healthcare Sector # 60
Overall Market # 919

Receivable Turnover Ratio Statistics
High Average Low
20.46 16.67 12.89
(Jun 30 2012)   (Sep 30 2012)





BMTI Company Profile • Back to BMTI Efficiency Comparisons • Compare BMTI Receivables Turnover Ratio to its Competitors

Financial Statements
Biomimetic Therapeutics's Accounts Receivable $ 0 Millions Visit BMTI's Balance sheet
Biomimetic Therapeutics's Sales TTM $ 2 Millions Visit BMTI's Income Statement
Sources of BMTI's Revenues Visit BMTI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BMTI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BMTI's Growth Rates BMTI's Roa BMTI's Inventory Turnover Ratio BMTI's Dividend Comparisons
BMTI's Profitability Ratios BMTI's Roi BMTI's Asset Turnover Ratio BMTI's Dividend Growth
BMTI's Valuation Ratios BMTI's Roe BMTI's Financial Strength Ratios BMTI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2012, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2012 Receivable at quarter ending Sep 30 2012
Athersys Inc  16.11 $ 8.984  Millions$ 0.558  Millions
Therapeuticsmd Inc   15.33 $ 3.132  Millions$ 0.204  Millions
Pacira Biosciences inc   15.21 $ 32.868  Millions$ 2.162  Millions
Chemed Corporation  15.20 $ 1,411.719  Millions$ 92.886  Millions
Interpace Biosciences Inc   14.98 $ 129.550  Millions$ 8.648  Millions
Vaxart Inc   14.20 $ 3.988  Millions$ 0.281  Millions
Procyon Corporation  13.95 $ 2.820  Millions$ 0.202  Millions
Sanomedics, Inc.  13.93 $ 0.082  Millions$ 0.006  Millions
Achari Ventures Holdings Corp I  13.09 $ 108.029  Millions$ 8.253  Millions
Pacific Biosciences Of California Inc   13.07 $ 32.549  Millions$ 2.491  Millions
Acorda Therapeutics Inc   13.03 $ 296.985  Millions$ 22.797  Millions
Biomimetic Therapeutics, Inc.  12.89 $ 2.050  Millions$ 0.159  Millions
Amag Pharmaceuticals inc   12.49 $ 79.141  Millions$ 6.338  Millions
Cutera Inc   12.35 $ 73.286  Millions$ 5.934  Millions
Novavax inc   12.20 $ 23.355  Millions$ 1.914  Millions
Immucell Corporation  12.19 $ 5.274  Millions$ 0.433  Millions
Nanomix Corp  12.15 $ 0.025  Millions$ 0.002  Millions
Vbi Vaccines Inc  12.12 $ 10.970  Millions$ 0.905  Millions
Adynxx, Inc.  12.12 $ 0.989  Millions$ 0.082  Millions
Dendreon Corp  11.73 $ 442.182  Millions$ 37.712  Millions
Neurometrix Inc   11.56 $ 8.412  Millions$ 0.728  Millions
Rockwell Medical inc   11.39 $ 48.739  Millions$ 4.278  Millions
Genmark Diagnostics Inc   11.38 $ 13.061  Millions$ 1.148  Millions
Bio techne Corp  11.36 $ 311.989  Millions$ 27.475  Millions
American Caresource Holdings, Inc.  11.20 $ 38.827  Millions$ 3.467  Millions
Ligand Pharmaceuticals Incorporated  11.08 $ 30.690  Millions$ 2.769  Millions
Genomic Health Inc  10.92 $ 228.143  Millions$ 20.885  Millions
International Stem Cell Corporation  10.84 $ 4.381  Millions$ 0.404  Millions
Apyx Medical Corp  10.75 $ 27.002  Millions$ 2.511  Millions
Surmodics Inc   10.67 $ 52.382  Millions$ 4.910  Millions

Date modified: 2026-09-08T15:07:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.